Login With Google
China gives go-ahead for human trials of COVID-19 vaccine
Why is it in news?
- China has given the go-ahead for researchers to begin human safety tests of an experimental coronavirus vaccine in the race to develop a shot against the COVID-19 epidemic that has killed more than 7,000 people worldwide.
More in news
- More about the trials
(1) Details in the Chinese clinical trial registration database show that a “Phase 1” test that will examine whether experimental shot is safe in humans aims to recruit 108 healthy people.
(2) The volunteers will take part in the study to take place between March 16 and December 31.
(3) The trial will be conducted by China’s Academy of Military Medical Sciences and the Hong Kong-listed biotech firm CanSino Biologics.
- Vaccine being tested by U.S.: Scientists in the United States said on Monday that clinical trials had begun for a vaccine developed by its National Institute of Allergy and Infectious Diseases and the U.S. biotech firm Moderna.
Source
The Hindu